Ironwood Pharmaceuticals Inc (IRWD) stock
IRWDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/3062% below fair value
$4.85+0.02 (+0.41%)
Close on Nov 16, 2026Market cap $801.41MP/E 6.3Yield –
Ironwood Pharmaceuticals enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Ironwood Pharmaceuticals's enterprise value was $715.68M on Nov 10, 2026, against $428.97M a year earlier. Over the last 5 years it ranged from -$11.54M to $2.10B, with a median of $914.86M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 10, 2026 | $715.68M | +75.5% |
| 2025 | Dec 31, 2025 | $407.82M | -34.3% |
| 2024 | Dec 31, 2024 | $620.66M | -62.9% |
| 2023 | Dec 29, 2023 | $1.67B | +26.3% |
| 2022 | Dec 30, 2022 | $1.33B | -8.7% |
| 2021 | Dec 31, 2021 | $1.45B | -4.2% |
| 2020 | Dec 31, 2020 | $1.52B | -22.2% |
| 2019 | Dec 31, 2019 | $1.95B | +320.0% |
| 2017 | Jan 31, 2017 | $463.78M | -6.6% |
| 2016 | Dec 30, 2016 | $496.36M | -55.7% |
| 2015 | Dec 31, 2015 | $1.12B | -47.6% |
| 2014 | Dec 31, 2014 | $2.14B | +116.9% |
| 2013 | Dec 31, 2013 | $985.52M | -6.4% |
| 2012 | Dec 31, 2012 | $1.05B | -6.1% |
| 2011 | Dec 30, 2011 | $1.12B | – |
| 2010 | Dec 31, 2010 | -$48.65M | – |
See a number that looks wrong?